Clinical Evidence: What the Trials Actually Show
Which Is Better Mounjaro or Wegovy: Understanding the Mechanism Difference
The question of which is better between Mounjaro or Wegovy requires understanding their distinct mechanisms of action rather than seeking a simple answer. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural fullness hormones to reduce appetite and promote satiety after smaller meals. Mounjaro, containing tirzepatide, works as a dual agonist targeting both GIP and GLP-1 receptors, potentially offering broader metabolic effects. Both are prescription-only medicines that must be prescribed alongside a reduced-calorie diet and increased physical activity.
When patients ask which is better Mounjaro or Wegovy, prescribers typically consider individual patient factors including medical history, concurrent medications, and specific weight-related comorbidities. The dual-receptor approach of Mounjaro may appeal to some patients, whilst others may prefer Wegovy's well-established GLP-1 pathway with extensive long-term safety data. Both medications require careful dose escalation and ongoing medical supervision through a GPhC-registered pharmacy like EverydayMeds (#9012878).
Wegovy Pricing Structure: Transparent Costs for UK Patients
Understanding the financial commitment helps patients determine which is better Mounjaro or Wegovy for their individual circumstances. Wegovy pricing at EverydayMeds begins with the 0.25mg starter dose at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the maintenance 2.4mg dose at £209.99. New patients can apply discount code FIRST40 at checkout, whilst returning customers benefit from code DOSE25. The structured dose escalation means patients gradually increase their investment as they progress through the titration schedule.
Bundle options provide convenience for patients committed to their weight management journey, such as the Intro Duo (0.25mg & 0.5mg) for £169.99 or the Progress Trio (0.5mg, 1mg & 1.7mg) for £369.99. These bundles ensure continuity of supply without requiring multiple orders, particularly valuable given the prescription-only nature of both Wegovy and Mounjaro. The Ultimate Stability Trio provides three months of maintenance 2.4mg supply for £649.99, offering peace of mind for established patients who have determined which is better Mounjaro or Wegovy for their needs.
STEP Trial Evidence: What Wegovy Clinical Data Reveals
Clinical evidence provides crucial insights when determining which is better Mounjaro or Wegovy for individual patients. The landmark STEP 1 trial demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 3 showed enhanced results of around 16% when combined with intensive behavioural therapy, whilst STEP 5 demonstrated sustained weight loss of 15.2% maintained over two years.
The SELECT cardiovascular outcomes trial revealed an additional dimension to Wegovy's clinical profile, with a 20% reduction in major cardiovascular events (HR 0.80) in patients with established cardiovascular disease. These results cannot be directly compared to Mounjaro trials due to different study designs, populations, and endpoints, which is why the question of which is better Mounjaro or Wegovy requires individualised clinical assessment rather than blanket recommendations.
GLP-1 Mechanism: How Wegovy Supports Weight Management
Wegovy's semaglutide acts as a GLP-1 receptor agonist, mimicking the natural incretin hormone that signals satiety to the brain's appetite control centres. This mechanism may help reduce food cravings and promote feelings of fullness after smaller portions, supporting patients' efforts to maintain a reduced-calorie diet. The once-weekly injection using Novo Nordisk's FlexTouch pen technology provides consistent medication levels throughout the week, avoiding the daily dosing requirements of some alternative treatments. As a prescription-only medicine, Wegovy requires ongoing medical supervision to monitor effectiveness and adjust dosing as needed. The medication works most effectively when combined with lifestyle modifications, making it a tool to support rather than replace healthy eating and physical activity habits.
Streamlined Ordering: From Assessment to Delivery
EverydayMeds simplifies access to both Wegovy and Mounjaro through a comprehensive online service designed for UK patients. The process begins with a 3-minute clinical assessment covering medical history, current medications, and weight management goals, ensuring appropriate prescribing for either treatment option. Qualified prescribers review each application within 3 working days (or 24 hours with express service), applying the same clinical standards used in traditional healthcare settings. Once approved, medications are dispatched via next-day delivery using specialised cold-chain packaging to maintain the 2-8°C storage requirements throughout transit. This temperature-controlled system ensures medication integrity from our GPhC-registered pharmacy (#9012878) directly to patients' refrigerators, eliminating concerns about storage compliance during delivery.
Storage Considerations: Practical Differences Between Treatments
Storage requirements present a practical consideration when evaluating which is better Mounjaro or Wegovy for individual lifestyles. Both medications require refrigeration at 2-8°C before first use, but Wegovy offers superior room temperature stability, maintaining effectiveness for up to 6 weeks when stored below 30°C after removal from the fridge. Mounjaro's room temperature tolerance is limited to 21 days, potentially creating challenges for patients who travel frequently or have unreliable refrigeration access. The FlexTouch pen design used for Wegovy provides consistent dosing accuracy and ease of use, with clear dose escalation markings to support the mandatory titration schedule. Patients must follow the prescribed dose progression from 0.25mg through to 2.4mg maintenance dosing, as skipping escalation steps is not recommended. Proper storage and handling ensure optimal medication effectiveness regardless of which treatment patients ultimately choose.
UK-Specific Considerations: Which Is Better Mounjaro or Wegovy for British Patients
British patients face unique considerations when determining which is better Mounjaro or Wegovy, particularly regarding NHS availability and private prescription costs. Wegovy received NICE recommendation TA875 for specialist weight management services, though access remains limited through standard NHS pathways. Private prescription access through platforms like EverydayMeds provides immediate availability for both treatments, with transparent pricing and no hidden consultation fees.
The UK's variable climate and frequent travel to European destinations makes Wegovy's extended room temperature stability particularly relevant for British patients. Additionally, the established prescribing patterns among UK weight management specialists often favour treatments with extensive long-term safety data, which may influence clinical recommendations. Both medications require ongoing medical supervision, making the choice between treatments a collaborative decision between patient and prescriber rather than a predetermined superiority ranking.
Making Your Decision: Expert Guidance Available
Rather than declaring which is better Mounjaro or Wegovy definitively, the evidence supports individualised treatment selection based on patient-specific factors. Both medications represent significant advances in prescription weight management, with robust clinical evidence supporting their effectiveness when used alongside appropriate lifestyle modifications. EverydayMeds provides access to both treatments through the same streamlined service, with experienced prescribers available to discuss the relative merits of each option based on your medical history and treatment goals. Our clinical team understands that effective weight management requires the right medication match for each individual patient, supported by ongoing professional guidance throughout the treatment journey. New patients can begin their assessment today using discount code FIRST40, whilst existing patients benefit from code DOSE25 for continued treatment access.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
